Search - tctmd.com

Displaying 241 - 260 of 543

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

Michael O'Riordan

July 05, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Daily News

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Michael O'Riordan

July 05, 2016

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

Presentation TVT 2016

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

Presenter: Vinod H. Thourani

June 16, 2016

Presentation TVT 2016

TVT 1079: What Is This New Jet?! Acquired AortoRight Ventricular Fistula After Sapien 3 TAVR

Presenter: Hasan Ahmad, MD

June 16, 2016

Presentation TVT 2016

TVT 1098: Stuck Leaflet After Transcatheter Aortic Valve Replacement With a SAPIEN 3 Valve: New Valve... Old Complication

Presenter: Jean-Michel Paradis

June 16, 2016

Presentation TVT 2016

The SAPIEN 3 TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

Presenter: Susheel Kodali

June 16, 2016

Presentation TVT 2016

TVT 1139: Transfemoral Aortic and Transseptal Mitral Valve Replacements Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

Presenter: Firas Zahr, MD

June 16, 2016

Presentation TVT 2016

TVT 1126: On-Pump Beating-Heart Direct Transatrial Implantation of Edwards Sapien 3 Valve for Mitral Stenosis With Severely Calcified Annulus

Presenter: Mohammad Sarraf, MD

June 16, 2016

Presentation TVT 2016

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

Presenter: Vikas Aggarwal, MD

June 16, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

News Industry News

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

May 17, 2016

Advertisement

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

TAVR 可用于治疗二尖瓣主动脉瓣狭窄，但与永久性起搏器植入率更高相关联

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

La Intervención TAVR para el Manejo de la Estenosis de la Válvula Aórtica Bicúspide es Viable pero se asocia a un Índice Más Alto de Implantación de Marcapasos Permanente

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

What TAVR Needs Next . . . and What It’s Getting

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Highlights From the SAPIEN 3 Experience in Intermediate-Risk Patients

TVT 1079: What Is This New Jet?! Acquired AortoRight Ventricular Fistula After Sapien 3 TAVR

TVT 1098: Stuck Leaflet After Transcatheter Aortic Valve Replacement With a SAPIEN 3 Valve: New Valve... Old Complication

The SAPIEN 3 TAVR System: Design Features, Special Attributes, and Brief Clinical Trial Status

TVT 1139: Transfemoral Aortic and Transseptal Mitral Valve Replacements Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves

TVT 1126: On-Pump Beating-Heart Direct Transatrial Implantation of Edwards Sapien 3 Valve for Mitral Stenosis With Severely Calcified Annulus

TVT 1036: Concurrent Transcatheter Double Valve Replacement: First Report of Sapien 3 Implantation in Native Aortic and Mitral Annuli in the Same Setting

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content